None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women desirous of long-term reversible contraception. 2.Patients who fulfil the WHO ‘Medical eligibility criteria for contraceptive use’ (Annexure I). 3.Patients who are willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Women who are not willing to participate in the study. 2. Women with structural malformations of the uterus, cervix and vagina and presence of fibroids. 13 3. Women with severe anaemia, uncontrolled diabetes, thrombocytopenia, any bleeding disorder. 4. Women with active genital tract infection/ pelvic inflammatory disease (PID). 5. Women with concurrent pregnancy. 6. Women with genital tract bleeding of unknown cause. 7. Women with prior history of ectopic pregnancy/ scarred uterus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the proper placement of the IUD in the uterus with the newer cross glide technique.Timepoint: immediately after insertion procedure & after 6 weeks of insertion procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the VAS score for pain perceived by the patient and ease of insertion for the doctor.Timepoint: immediately after the insertion procedure. | — |
Countries
India
Contacts
Post graduate institute of medical education and research, chandigarh